Avid Bioservices Inc (CDMO)

[biopharm]

I figured "one" of the newly approved BP FDA drugs wanted a trial within a trial and had the opportunity to do so after Sunrise stopped due to abnormally high control arm (advised by DMC) where Docetaxel performed like never before...and the BP would get a glimpse of how their newly approved IO drug performed with patients immune systems PRIMED with a PS Targeting drug...

OR was it the Mastermind of Peregrine to give each of them a glimpse of how well it would work, SINCE the opportunity had risen due to the DMC advising to stop the trial ....yet we know now it was due to a broken FDA trial system that even FDA admits..

But hey.....Peregrine may have that leverage now and did Patients live longer ....not meet MOS yet..that were on Bavi PS Targeting before combining so to speak with a new IO approved drug?

Looks like yes and now what other Biomarkers were extracted from Sunrise in combination with their future IO drug???

Nov 8. 2017 we may know.....Epiontis and their new buyer PRECISION FOR MEDICINE KNOWS SOMETHING...is what I saymu